As the largest resource of information specific to women's brain health, we are sure you will find what you are looking for, and promise that you will discover new information.
Published on: July 2, 2012
by The Press Association:
Chronic inflammation early in life may leave the brain vulnerable to Alzheimer’s disease, research has suggested.
Scientists made the discovery after triggering persistent inflammation in unborn mice.
A single infection during late pregnancy was enough to induce long-term neurological changes and memory problems in old age. The mice developed boosted levels of immune system signalling molecules linked to inflammation.
If the immune system challenge was repeated in adulthood the effect was strongly amplified, resulting in changes similar to those seen in Alzheimer’s patients. Mice genetically modified to produce a human version of the Alzheimer’s-associated brain protein amyloid-beta showed the most striking reaction.
“It seems likely that chronic inflammation due to infection could be an early event in the development of Alzheimer’s disease,” said study leader Dr Irene Knuesel, from the University of Zurich in Switzerland.
The research is published in the Journal of Neuroinflammation. If the findings can be shown to apply to humans, it would suggest a role for anti-inflammatory drugs in treating Alzheimer’s.
Dr Marie Janson, from the charity Alzheimer’s Research UK, said: “The results of this study suggest that repeated or severe infections may contribute to the development of Alzheimer’s disease in mice.
“While we know that the immune system plays a role in human Alzheimer’s disease, clinical trials with anti-inflammatory drugs have not yet shown conclusive benefits in treating the disease and so more research is needed to fit these pieces of the puzzle together.
“Understanding the risk factors for Alzheimer’s disease is essential, especially if some of these factors are things that we can actively change or avoid. This understanding can only come through research, yet research into dementia remains hugely underfunded.”
Thirty-six million people worldwide suffer from Alzheimer’s disease and dementia. In Canada, 25,000 new cases are diagnosed each year. Those sobering numbers have researchers around the globe racing to come up with new ways to...
he Food and Drug Administration issued new guides on drug development for neurological disorders. This sets the stage for possible treatments for Alzheimer’s. The disease-oriented development guide documents will provide details on how researchers...
For young adults with autosomal dominant Alzheimer’s disease (AD), molecular markers can identify changes associated with the disease before clinical onset, according to a study published online Feb. 12 in JAMA Neurology. Yakeel T. Quiroz, Ph.D., from Massachusetts...
The material presented through the Think Tank feature on this website is in no way intended to replace professional medical care or attention by a qualified practitioner. WBHI strongly advises all questioners and viewers using this feature with health problems to consult a qualified physician, especially before starting any treatment. The materials provided on this website cannot and should not be used as a basis for diagnosis or choice of treatment. The materials are not exhaustive and cannot always respect all the most recent research in all areas of medicine.